Modified SALT Score for Alopecia Areata

Last updated: May 29, 2020
Sponsor: Kasr El Aini Hospital
Overall Status: Active - Recruiting

Phase

4

Condition

Hair Loss

Alopecia

Treatment

N/A

Clinical Study ID

NCT04412148
EgymSALT
  • Ages 18-60
  • All Genders

Study Summary

Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6months) • patients who did not receive any medication for at least 2 months beforestarting the study and those who agreed to join the study and signed written consent.

Exclusion

Exclusion Criteria:

  • • pregnant, and lactating females

  • Alopecia totalis or universalis or ophiasis or cicatritial alopecia

  • Usage of systemic treatment of alopecia areata 2 months prior to the study.

  • Any scalp lesion within the treated area

  • Bleeding diathesis, severe anemia or platelet disorders

  • Medical conditions such as autoimmune diseases.

Study Design

Total Participants: 20
Study Start date:
January 01, 2020
Estimated Completion Date:
August 01, 2020

Connect with a study center

  • Kasr El Ainy university hospital, Faulty of medicine,Cairo university

    Cairo,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.